Displaying results 121 - 132 of 159
General Hepatology
Novel point-of-care, rapid breath test to identify subjects with metabolic-dysfunction associated steatotic liver disease with advanced fibrosis - a pilot study

Novel point-of-care, rapid breath test to identify subjects with metabolic-dysfunction associated steatotic liver disease with...

ePosters
View
General Hepatology
Digital communication intervention and weight loss in patients with metabolic dysfunction-associated steatotic liver disease: A randomised controlled Study

Digital communication intervention and weight loss in patients with metabolic dysfunction-associated steatotic liver disease: ...

ePosters
View
General Hepatology
MASLD and fibrosis status in patients with type 2 diabetes treated at internal medicine clinics: Türkiye DAHUDER awareness of steatotic liver disease (TR-DASLD) study

MASLD and fibrosis status in patients with type 2 diabetes treated at internal medicine clinics: Türkiye DAHUDER awareness of ...

ePosters
View
General Hepatology
A human stem cell-based hepatic model as a tool for metabolic dysfunction-associated steatotic liver disease modeling and drug screening

A human stem cell-based hepatic model as a tool for metabolic dysfunction-associated steatotic liver disease modeling and drug...

ePosters
View
General Hepatology
Impact of hepatitis C eradication with direct-acting antivirals on metabolic and liver-related outcomes in diabetic patients: A long-term prospective analysis

Impact of hepatitis C eradication with direct-acting antivirals on metabolic and liver-related outcomes in diabetic patients: ...

ePosters
View
General Hepatology
Prevalence of steatotic liver disease in people living with HIV and high prevalence of cardiovascular risk factors

Prevalence of steatotic liver disease in people living with HIV and high prevalence of cardiovascular risk factors

ePosters
View
General Hepatology
Relationship between endothelial dysfunction and metabolic dysfunction-associated steatotic liver disease

Relationship between endothelial dysfunction and metabolic dysfunction-associated steatotic liver disease

ePosters
View
General Hepatology
Screening of advanced liver fibrosis and metabolic dysfunction-associated steatotic liver disease assessed by transient elastography in Roma population

Screening of advanced liver fibrosis and metabolic dysfunction-associated steatotic liver disease assessed by transient elasto...

ePosters
View
General Hepatology
Metabolic associated steatotic liver disease and mental illness: role of fibroblast growth factor-21

Metabolic associated steatotic liver disease and mental illness: role of fibroblast growth factor-21

ePosters
View
General Hepatology
Assessing the impact of glucagon-like peptide-1 receptor agonists in metabolic dysfunction associated steatosis liver disease

Assessing the impact of glucagon-like peptide-1 receptor agonists in metabolic dysfunction associated steatosis liver disease

ePosters
View
General Hepatology
Effect of constitutive androstane receptor activation on hepatic unsaturated triglyceride levels

Effect of constitutive androstane receptor activation on hepatic unsaturated triglyceride levels

ePosters
View
General Hepatology
Arsenic as a risk factor for metabolic-associated steatotic liver disease (MASLD): A mechanistic study

Arsenic as a risk factor for metabolic-associated steatotic liver disease (MASLD): A mechanistic study

ePosters
View